This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, Y. L. Articles by Mano, H. Search for Related Content PubMed PubMed Citation Articles by Choi, Y. L. Articles by Mano, H.

Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non–Small Cell Lung Cancer

Divisions of ¹ Functional Genomics and ² Pulmonary Medicine, Jichi Medical University, Tochigi, Japan; ³ Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; and ⁴ CREST, Japan Science and Technology Agency, Saitama, Japan

Requests for reprints: Hiroyuki Mano, Division of Functional Genomics, Jichi Medical University, 3311-1 Yakushiji, Shimotsukeshi, Tochigi 329-0498, Japan. Phone: 81-285-58-7449; Fax: 81-285-44-7322; E-mail: hmano{at}jichi.ac.jp.

Key Words: lung cancer • oncogene • EML4-ALK • protein tyrosine kinase • isoform

The genome of a subset of non–small-cell lung cancers (NSCLC) harbors a small inversion within chromosome 2 that gives rise to a transforming fusion gene, EML4-ALK, which encodes an activated protein tyrosine kinase. Although breakpoints within EML4 have been identified in introns 13 and 20, giving rise to variants 1 and 2, respectively, of EML4-ALK, it has remained unclear whether other isoforms of the fusion gene are present in NSCLC cells. We have now screened NSCLC specimens for other in-frame fusion cDNAs that contain both EML4 and ALK sequences. Two slightly different fusion cDNAs in which exon 6 of EML4 was joined to exon 20 of ALK were each identified in two individuals of the cohort. Whereas one cDNA contained only exons 1 to 6 of EML4 (variant 3a), the other also contained an additional 33-bp sequence derived from intron 6 of EML4 (variant 3b). The protein encoded by the latter cDNA thus contained an insertion of 11 amino acids between the EML4 and ALK sequences of that encoded by the former. Both variants 3a and 3b of EML4-ALK exhibited marked transforming activity in vitro as well as oncogenic activity in vivo. A lung cancer cell line expressing endogenous variant 3 of EML4-ALK underwent cell death on exposure to a specific inhibitor of ALK catalytic activity. These data increase the frequency of EML4-ALK–positive NSCLC tumors and bolster the clinical relevance of this oncogenic kinase. [Cancer Res 2008;68(13):4971–6]

This article has been cited by other articles:

				K. K.W. To, R. W. Robey, T. Knutsen, Z. Zhan, T. Ried, and S. E. Bates Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 Mol. Cancer Ther., October 1, 2009; 8(10): 2959 - 2968. [Abstract] [Full Text] [PDF]

				L. Horn and W. Pao EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer J. Clin. Oncol., September 10, 2009; 27(26): 4232 - 4235. [Full Text] [PDF]

				E. Lin, L. Li, Y. Guan, R. Soriano, C. S. Rivers, S. Mohan, A. Pandita, J. Tang, and Z. Modrusan Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers Mol. Cancer Res., September 1, 2009; 7(9): 1466 - 1476. [Abstract] [Full Text] [PDF]

				F. J. Kaye Mutation-associated fusion cancer genes in solid tumors Mol. Cancer Ther., June 1, 2009; 8(6): 1399 - 1408. [Abstract] [Full Text] [PDF]

				K. Takeuchi, Y. L. Choi, Y. Togashi, M. Soda, S. Hatano, K. Inamura, S. Takada, T. Ueno, Y. Yamashita, Y. Satoh, et al. KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer Clin. Cancer Res., May 1, 2009; 15(9): 3143 - 3149. [Abstract] [Full Text] [PDF]

				M. P. Martelli, G. Sozzi, L. Hernandez, V. Pettirossi, A. Navarro, D. Conte, P. Gasparini, F. Perrone, P. Modena, U. Pastorino, et al. EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues Am. J. Pathol., February 1, 2009; 174(2): 661 - 670. [Abstract] [Full Text] [PDF]

				M. Soda, S. Takada, K. Takeuchi, Y. L. Choi, M. Enomoto, T. Ueno, H. Haruta, T. Hamada, Y. Yamashita, Y. Ishikawa, et al. A mouse model for EML4-ALK-positive lung cancer PNAS, December 16, 2008; 105(50): 19893 - 19897. [Abstract] [Full Text] [PDF]